SCHEMBL2237249

SCHEMBL2237249

CC(=O)CCOc1ccc(C2C(=O)Oc3c2cc(C(C)(C)C)cc3C(C)(C)C)cc1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 1/20 0.34
GABBR1 Q9UBS5 1/20 0.34
ALDH1A1 P00352 4/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
ESR1 P03372 2/20 0.32
ESR2 Q92731 2/20 0.32
GPR35 Q9HC97 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PPARG P37231 3/20 0.32
FFAR1 O14842 2/20 0.32
PPARD Q03181 2/20 0.32
PPARA Q07869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26459763 0.90 ALDH1A1 (0.36) GABBR2GABBR1ALDH1A1POLBRAB9A
SCHEMBL26459778 0.89 ALDH1A1 (0.35) GABBR2GABBR1ALDH1A1POLBRAB9A
SCHEMBL39951 0.89 APP (0.36) GABBR2GABBR1ALDH1A1POLBRAB9A
SCHEMBL29478052 0.89 SMN1; SMN2 (0.37) GABBR2GABBR1ALDH1A1POLBRAB9A
SCHEMBL493787 0.89 SMN1; SMN2 (0.37) GABBR2GABBR1ALDH1A1POLBRAB9A
SCHEMBL26459779 0.88 ALDH1A1 (0.35) GABBR2GABBR1ALDH1A1POLBRAB9A
SCHEMBL26459782 0.88 ALDH1A1 (0.35) GABBR2GABBR1ALDH1A1POLBRAB9A
SCHEMBL26459777 0.88 ALDH1A1 (0.36) GABBR2GABBR1ALDH1A1KDM4EHPGD
SCHEMBL12679255 0.87 MEN1 (0.35) GABBR2GABBR1ALDH1A1POLBRAB9A
SCHEMBL21183326 0.87 GABBR2 (0.33) GABBR2GABBR1ALDH1A1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10759780-B2 Hindered amines 3V SIGMA S.P.A. (IT) 2020-09-01 US disclosed
US-20200239629-A1 HINDERED POLYMERIC AMINES 3V SIGMA S.P.A. (IT) 2020-07-30 US disclosed
EP-3424977-B1 HINDERED POLYMERIC AMINES 3V SIGMA SPA (IT) 2020-03-18 EP disclosed
EP-3428156-B1 HINDERED AMINES 3V SIGMA SPA (IT) 2020-02-12 EP disclosed
US-20190016702-A1 HINDERED AMINES 3V SIGMA S.P.A. (IT) 2019-01-17 US disclosed
EP-3428156-A1 HINDERED AMINES 3V SIGMA S.p.A (IT) 2019-01-16 EP disclosed
EP-3424977-A1 HINDERED POLYMERIC AMINES 3V SIGMA S.p.A (IT) 2019-01-09 EP disclosed
US-20190002631-A1 HINDERED POLYMERIC AMINES 3V SIGMA S.P.A. (IT) 2019-01-03 US disclosed
EP-2112141-B1 Oligomeric sterically hindered amines and their use as polymer stabilizers 3V SIGMA SPA (IT) 2013-05-15 EP disclosed
US-8003718-B2 Oligomeric sterically hindered amines and their use as polymer stabilisers 3V SIGMA S.P.A. (IT) 2011-08-23 US disclosed
US-20090270536-A1 OLIGOMERIC STERICALLY HINDERED AMINES AND THEIR USE AS POLYMER STABILISERS 3V SIGMA S.P.A. (IT) 2009-10-29 US disclosed
EP-2112141-A1 Oligomeric sterically hindered amines and their use as polymer stabilizers 3V SIGMA S.p.A (IT) 2009-10-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200239629-A1 HINDERED POLYMERIC AMINES PARG, PARN, PUF60 GABBR2 3248/4885GABBR1 3080/4885ALDH1A1 884/4885
US-20090270536-A1 OLIGOMERIC STERICALLY HINDERED AMINES AND THEIR USE AS POLYMER STABILISERS PCBP1, PARG, PARN GABBR2 3805/4885GABBR1 3838/4885ALDH1A1 1222/4885
US-20190016702-A1 HINDERED AMINES PARG, TAAR5, PARN GABBR2 2603/4885GABBR1 2263/4885ALDH1A1 638/4885
US-10759780-B2 Hindered amines PARG, TAAR5, PARN GABBR2 2603/4885GABBR1 2263/4885ALDH1A1 638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.